Related Experiment Video
Updated: May 29, 2025

Cholesterol Efflux Assay
Published on: March 6, 2012
Caveolin-1-mediated LDL transcytosis across endothelial cells in atherosclerosis
Yifei Zhang1, Xiong Jia2, Yayu Wang2
1Department of Cardiovascular Surgery, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, 518020, China.
Insights
Caveolin-1 plays a key role in transporting low-density lipoprotein (LDL) across endothelial cells, contributing to atherosclerosis development. Understanding this mechanism offers new therapeutic targets for early-stage atherosclerosis treatment.
Area of Science:
- Cardiovascular Biology
- Cellular Biology
- Molecular Medicine
Background:
- Atherosclerosis is a chronic inflammatory arterial disease driven by lipid accumulation.
- Low-density lipoprotein (LDL) deposition in the arterial wall is central to atherosclerosis pathogenesis.
- Caveolin-1, an endothelial cell membrane protein, is implicated in LDL transport.
Purpose of the Study:
- To review the role of caveolin-1 in mediating low-density lipoprotein (LDL) transcytosis across endothelial cells.
- To elucidate the mechanisms by which caveolin-1 influences atherosclerosis development and progression.
- To identify caveolin-1 as a potential therapeutic target for atherosclerosis.
Main Methods:
- Comprehensive review of existing scientific literature.
- Analysis of studies investigating caveolin-1 function in endothelial cells.
- Synthesis of research on caveolin-1's role in membrane trafficking, cholesterol metabolism, and signaling pathways relevant to atherosclerosis.
Main Results:
- Caveolin-1 is crucial for the transcytosis of LDL across the endothelium.
- Caveolin-1 modulates key cellular processes involved in atherosclerosis.
- Evidence supports caveolin-1's involvement in both the initiation and advancement of atherosclerosis.
Conclusions:
- Caveolin-1 is a critical mediator of LDL endothelial transport in atherosclerosis.
- Targeting caveolin-1 presents a promising strategy for novel atherosclerosis therapies.
- Further research into caveolin-1 pathways can inform early-stage atherosclerosis treatment approaches.
Abstract:
Atherosclerosis is widely recognized as a chronic inflammatory disease of the arterial wall characterized by the progressive accumulation of lipids, inflammatory cells, and fibrous material in the subendothelial space of large arteries. The occurrence and pathogenesis of atherosclerosis are intricately linked to the deposition of low-density lipoprotein (LDL) in the arterial wall. LDL must cross the intact endothelium to reach the subendothelial space, with caveolin-1 assuming a crucial role in this process. Caveolin-1 is a 21-24 kDa membrane protein located in caveolae and highly expressed in endothelial cells. Previous investigations have demonstrated the pivotal role of caveolin-1 in fostering atherosclerosis through its modulation of membrane trafficking, cholesterol metabolism, and cellular signaling. However, how caveolin-1 regulates LDL transcytosis across endothelial cells in atherosclerosis remains unclear. We provide a comprehensive overview of recent research on the interplay between caveolin-1 and atherosclerosis, with a specific focus on elucidating the role of caveolin-1 in mediating LDL transcytosis across endothelial cells. This review furnishes theoretical foundations supporting the pivotal role of caveolin-1 in both the inception and progression of atherosclerosis. It underscores the prospective viability of caveolin-1 as a new therapeutic target for atherosclerosis and introduces novel perspectives for treatment strategies in the early stages of atherosclerosis.
Related Concept Videos
Receptor-mediated Endocytosis
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Inflammation
Clathrin Coated Vesicles
The Early Endosome: Endocytosis of Transferrin

